Jacob Fredsted

Jacob Fredsted is a Senior Scientist in Drug Substance Development at Hemab Therapeutics, where they focus on delivering quality solutions in the Life Sciences sector. Previously, Jacob served as a CMC Specialist in Downstream Processing at Genmab and as a Process Transfer Scientist at AGC Biologics, where they managed process transfers and optimizations. Jacob's earlier experience includes roles as a Chemist at Novo Nordisk, responsible for API manufacturing processes, and as a Research Assistant at the University of Copenhagen, contributing to a publication on prolactin signaling in breast cancer cells. Jacob holds a Master of Science in Biochemistry, specialized in protein chemistry, and a Bachelor of Science in the same field from Københavns Universitet.